ArticlePloS one2014

Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.

Fang-Jing Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.